US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

76.58

-2.9600-3.72%

Post-market: 76.36-0.2158-0.28%19:30 EDT

Volume:381.02K

Turnover:29.44M

Market Cap:3.42B

PE:-7.86

High:81.87

Open:81.87

Low:75.61

Close:79.54

52wk High:118.84

52wk Low:30.82

Shares:44.67M

Float Shares:40.64M

Volume Ratio:0.44

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7487

EPS(LYR):-11.1105

ROE:-16.12%

ROA:-12.03%

PB:1.35

PE(LYR):-6.89

Loading ...

Overview Company News Filings

Superpower: Strategic Partnership With Grail for Multi-Cancer Early Detection Test

THOMSON REUTERS

Superpower partners with Grail to offer Galleri cancer blood test to members

Grail Is Maintained at Buy by Guggenheim

Grail price target lowered to $75 from $130 at Guggenheim

GRAIL (GRAL) Valuation Check As CEO Transition And New Stock Shelf Shape Market Sentiment

Simply Wall St.

BUZZ-Grail rises after TD Cowen upgrade

Grail Shares up 3.7% Premarket After TD Cowen Raises to Buy From Hold

THOMSON REUTERS

Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)

Grail Inc : TD Cowen Raises to Buy From Hold; Cuts Target Price to $65 From $114

THOMSON REUTERS

Does GRAIL (GRAL) Elevating Josh Ofman to CEO Reframe Its Management Quality Narrative?

Simply Wall St.

Guggenheim Sticks to Their Buy Rating for GRAIL Inc (GRAL)

Canaccord Genuity Reaffirms Their Buy Rating on GRAIL Inc (GRAL)

Grail CEO Bob Ragusa Plans Retirement

MT Newswires Live

Levi & Korsinsky probes Grail over 50% stock drop after NHS Galleri trial miss

Grail Grants 19,500 RSUs to 20 New Hires Under Nasdaq Inducement Rule

Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Levi & Korsinsky Probes Grail Inc. for Possible Securities Fraud

Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. -- Barrons.com

GRAIL to Present at TD Cowen 46th Annual Health Care Conference

Levi & Korsinsky probes Grail Inc. for possible securities fraud

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GRAL/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":76.58,"timestamp":1787601600000,"preClose":79.54,"halted":0,"volume":381019,"hourTrading":{"tag":"盘后","latestPrice":76.3642,"preClose":76.58,"latestTime":"19:30 EDT","volume":9003,"amount":689454.1384,"timestamp":1787614203861,"change":-0.2158,"changeRate":-0.002818,"amplitude":0.002818},"delay":0,"changeRate":-0.03721398038722665,"floatShares":40644723,"shares":44666200,"eps":-9.748709,"marketStatus":"Closed","change":-2.96,"latestTime":"08-24 16:00:00 EDT","open":81.87,"high":81.87,"low":75.6101,"amount":29440650.771724,"amplitude":0.078701,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":79.54,"preHourTrading":{"tag":"盘前","latestPrice":81.46,"preClose":79.54,"latestTime":"09:28 EDT","volume":9936,"amount":807381.4155840001,"timestamp":1787578080154,"change":1.92,"changeRate":0.024139,"amplitude":0.030488},"postHourTrading":{"tag":"盘后","latestPrice":76.3642,"preClose":76.58,"latestTime":"19:30 EDT","volume":9003,"amount":689454.1384,"timestamp":1787614203861,"change":-0.2158,"changeRate":-0.002818,"amplitude":0.002818},"volumeRatio":0.436688,"impliedVol":0.8668,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":40644723,"roa":"-12.03%","roe":"-16.12%","lyrEps":-11.110457,"volumeRatio":0.436688,"shares":44666200,"dividePrice":0,"high":81.87,"amplitude":0.078701,"preClose":79.54,"low":75.6101,"week52Low":30.82,"pbRate":"1.35","psRate":"20.70","week52High":118.84,"institutionHeld":0,"latestPrice":76.58,"eps":-9.748709,"divideRate":0,"volume":381019,"delay":0,"ttmEps":-9.748709,"open":81.87,"prevYearClose":85.59,"prevWeekClose":79.54,"prevMonthClose":68.56,"prevQuarterClose":68.27,"fiveDayClose":69.95,"twentyDayClose":66.77,"sixtyDayClose":73.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"GRAL","fiscalQuarterEnding":"2026/06","expectedEps":-2.91,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-2.56},{"market":"US","date":"2026-05-05","symbol":"GRAL","fiscalQuarterEnding":"2026/03","expectedEps":3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2026-02-19","symbol":"GRAL","fiscalQuarterEnding":"2025/12","expectedEps":-3.33,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.2222,"hold":0.5556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2222,"analysts":9,"updateTime":1780718400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-08-21","current":-7.916659,"percent":0.089695,"low":-11.136928,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"high":-0.135365,"avg":-3.501538,"sd":3.477318,"marketCap":3482626264},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895},{"date":"2026-02-13","current":-9.201448,"twenty":-6.490935,"median":-0.634416,"eighty":-0.269888,"marketCap":3738005363},{"date":"2026-02-20","current":-10.027753,"twenty":-6.738169,"median":-0.640672,"eighty":-0.270458,"marketCap":4094842980},{"date":"2026-02-27","current":-5.738328,"twenty":-6.59852,"median":-0.642551,"eighty":-0.271707,"marketCap":2343252016},{"date":"2026-03-06","current":-5.1161,"twenty":-6.525603,"median":-0.645131,"eighty":-0.273298,"marketCap":2089164448},{"date":"2026-03-13","current":-4.454105,"twenty":-6.495818,"median":-0.656882,"eighty":-0.273627,"marketCap":1818838106},{"date":"2026-03-20","current":-4.868977,"twenty":-6.467497,"median":-0.678025,"eighty":-0.275336,"marketCap":1988251759},{"date":"2026-03-27","current":-5.23965,"twenty":-6.370491,"median":-0.694504,"eighty":-0.275763,"marketCap":2139616500},{"date":"2026-04-02","current":-5.384303,"twenty":-6.22661,"median":-0.703946,"eighty":-0.276019,"marketCap":2198685668},{"date":"2026-04-10","current":-4.777565,"twenty":-6.012578,"median":-0.718792,"eighty":-0.276332,"marketCap":1950923327},{"date":"2026-04-17","current":-4.969431,"twenty":-5.842655,"median":-0.720859,"eighty":-0.277189,"marketCap":2029272014},{"date":"2026-04-24","current":-5.087966,"twenty":-5.758444,"median":-0.724241,"eighty":-0.277697,"marketCap":2077675915},{"date":"2026-05-01","current":-5.472702,"twenty":-5.73481,"median":-0.732698,"eighty":-0.277887,"marketCap":2234783492},{"date":"2026-05-08","current":-6.830613,"twenty":-5.758444,"median":-0.740497,"eighty":-0.278585,"marketCap":2700312031},{"date":"2026-05-15","current":-6.709025,"twenty":-6.393277,"median":-0.747877,"eighty":-0.279728,"marketCap":2652245447},{"date":"2026-05-22","current":-7.366901,"twenty":-6.535065,"median":-0.752054,"eighty":-0.280426,"marketCap":2912320000},{"date":"2026-05-29","current":-8.024776,"twenty":-6.608933,"median":-0.75506,"eighty":-0.280871,"marketCap":3172394554},{"date":"2026-06-05","current":-7.224687,"twenty":-6.675155,"median":-0.757458,"eighty":-0.282109,"marketCap":2856099264},{"date":"2026-06-12","current":-6.530986,"twenty":-6.667338,"median":-0.770188,"eighty":-0.283378,"marketCap":2581862234},{"date":"2026-06-18","current":-6.453909,"twenty":-6.64758,"median":-0.774322,"eighty":-0.283727,"marketCap":2551391453},{"date":"2026-06-26","current":-7.226858,"twenty":-6.705551,"median":-0.790201,"eighty":-0.284901,"marketCap":2856957596},{"date":"2026-07-02","current":-7.394041,"twenty":-6.741593,"median":-0.791697,"eighty":-0.287059,"marketCap":2923049149},{"date":"2026-07-10","current":-8.227784,"twenty":-6.830613,"median":-0.793866,"eighty":-0.287218,"marketCap":3252648583},{"date":"2026-07-17","current":-7.811998,"twenty":-6.920316,"median":-0.805047,"eighty":-0.287691,"marketCap":3088278032},{"date":"2026-07-24","current":-7.638301,"twenty":-7.010823,"median":-0.819893,"eighty":-0.291185,"marketCap":3019611483},{"date":"2026-07-31","current":-7.722978,"twenty":-7.028862,"median":-0.830133,"eighty":-0.292962,"marketCap":3053086426},{"date":"2026-08-07","current":-7.231699,"twenty":-7.225121,"median":-0.842819,"eighty":-0.294422,"marketCap":2831839235},{"date":"2026-08-14","current":-7.783772,"twenty":-7.278539,"median":-0.870399,"eighty":-0.295212,"marketCap":3048023808},{"date":"2026-08-21","current":-8.893621,"twenty":-7.372329,"median":-0.87796,"eighty":-0.295699,"marketCap":3482626264}],"updateTime":1787584713800},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624548707","title":"Superpower: Strategic Partnership With Grail for Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2624548707","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624548707?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:10","pubTimestamp":1775063436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K1BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624548083","title":"Superpower partners with Grail to offer Galleri cancer blood test to members","url":"https://stock-news.laohu8.com/highlight/detail?id=2624548083","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624548083?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:10","pubTimestamp":1775063428,"startTime":"0","endTime":"0","summary":"Grail entered strategic partnership with Superpower to expand access to Galleri multi-cancer early detection blood test through Superpower platform.Superpower members will be able to add Galleri, which screens for cancer signals linked to more than 50 cancer types.PATHFINDER 2 study data showed adding Galleri to standard screenings increased cancer detection more than seven-fold.Offering targets adults at elevated cancer risk, including those aged 50 or older.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL8VgBWr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623442643","title":"Grail Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623442643","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623442643?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:35","pubTimestamp":1774884900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 30, 2026 11:35 ET (15:35 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312097","title":"Grail price target lowered to $75 from $130 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312097?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:54","pubTimestamp":1774871676,"startTime":"0","endTime":"0","summary":"Guggenheim lowered the firm’s price target on Grail (GRAL) to $75 from $130 and keeps a Buy rating on the shares. The firm adjusted models and fore...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-75-from-130-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-lowered-to-75-from-130-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621702682","title":"GRAIL (GRAL) Valuation Check As CEO Transition And New Stock Shelf Shape Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2621702682","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621702682?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:07","pubTimestamp":1774271221,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) is back in focus after announcing that CEO Bob Ragusa will retire in June 2026. President Josh Ofman will take over as CEO and Board member, and a new common stock shelf registration was filed.\nSee our latest analysis for GRAIL.\nThe leadership transition and new stock shelf arrive after a sharp 48.75% 90 day share price decline and a 47.29% negative year to date share price return. However, the 1 year total shareholder return of 45.78% indicates that longer term momentum has...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-ceo-transition-and-new-stock-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-ceo-transition-and-new-stock-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620023163","title":"BUZZ-Grail rises after TD Cowen upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2620023163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620023163?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:51","pubTimestamp":1773827497,"startTime":"0","endTime":"0","summary":"BUZZ-Grail rises after TD Cowen upgrade** Shares of diagnostics firm Grail GRAL.O rise 4.2% to $49.36 premarket** Brokerage TD Cowen upgrades GRAIL to “buy” from “hold”, but cuts its price target to $65 from $114** TD Cowen says the recent sell-off after the NHS Galleri trial miss has created an attractive entry point, despite the study missing its main goal** Brokerage says its expert checks remain positive on GRAIL’s blood test that aims to detect multiple cancers early, with a meaningful drop in late-stage cancers** TD Cowen estimates a roughly 75% chance of U.S. approval for the test and around a 50% chance of Medicare coverage** GRAIL shares had fallen about 60% since mid-February before the upgrade, brokerage says ** Shares rose nearly four fold in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N4060QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620623163","title":"Grail Shares up 3.7% Premarket After TD Cowen Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623163?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:50","pubTimestamp":1773827406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N4060QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620265231","title":"Analysts’ Top Healthcare Picks: GRAIL Inc (GRAL), Bicycle Therapeutics (BCYC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265231?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:50","pubTimestamp":1773827405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GRAIL Inc (GRAL – Research Report) and Bicycle Thera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-grail-inc-gral-bicycle-therapeutics-bcyc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","LABU","GRAL","BK4137","XLV","BCYC","XBI","BK4581","HCSG","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620392632","title":"Grail Inc : TD Cowen Raises to Buy From Hold; Cuts Target Price to $65 From $114","url":"https://stock-news.laohu8.com/highlight/detail?id=2620392632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620392632?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:37","pubTimestamp":1773826667,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4060N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620414159","title":"Does GRAIL (GRAL) Elevating Josh Ofman to CEO Reframe Its Management Quality Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414159","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620414159?lang=en_us&edition=fundamental","pubTime":"2026-03-17 09:23","pubTimestamp":1773710603,"startTime":"0","endTime":"0","summary":"In March 2026, GRAIL, Inc. announced that CEO Bob Ragusa will retire on June 1, 2026, with President Josh Ofman, MD, MSHS, set to become CEO and join the Board, while Ragusa remains as a senior advisor through March 2027.\nThis leadership transition places a long-time internal executive with deep clinical and health policy experience at the center of GRAIL’s next phase of development.\nNext, we’ll examine how Ofman’s planned move from president to CEO could reshape GRAIL’s investment narrative...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/does-grail-gral-elevating-josh-ofman-to-ceo-reframe-its-mana","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/does-grail-gral-elevating-josh-ofman-to-ceo-reframe-its-mana","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194509","title":"Guggenheim Sticks to Their Buy Rating for GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194509?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:58","pubTimestamp":1773403094,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Subbu Nambi from Guggenheim maintained a Buy rating on GRAIL Inc, with a price target of $130.00. The company’s sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619547194","title":"Canaccord Genuity Reaffirms Their Buy Rating on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619547194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619547194?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:57","pubTimestamp":1773403050,"startTime":"0","endTime":"0","summary":"In a report released today, Kyle Mikson CFA from Canaccord Genuity reiterated a Buy rating on GRAIL Inc, with a price target of $80.00. Mikson CFA ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-grail-inc-gral-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619155765","title":"Grail CEO Bob Ragusa Plans Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2619155765","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619155765?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:09","pubTimestamp":1773349797,"startTime":"0","endTime":"0","summary":"Grail  said late Thursday that Bob Ragusa will retire as chief executive officer, starting June 1.Grail president Josh Ofman will succeed Ragusa, the company said. Ofman was also appointed to the company's board of directors, effective immediately, according to a statement.Ragusa will remain on the board until June 1 and will serve in an advisory role through March 2027, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618213206","title":"Levi & Korsinsky probes Grail over 50% stock drop after NHS Galleri trial miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618213206","media":"Reuters","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618213206?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:04","pubTimestamp":1773320643,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky said it is investigating potential claims involving Grail after the company disclosed that its NHS Galleri randomized trial failed to meet its primary endpoint, and the stock fell about 50%. The firm cited comments from CEO Robert Ragusa on a Q3 2025 earnings call that Grail expected its cash runway to extend into 2030. It also cited CFO Aaron Freidin’s statement on the same call that 2025 cash burn would be no more than USD 290 million. Levi & Korsinsky is examining whether the company’s forward guidance omitted known risks tied to the NHS trial outcome. Shareholders are directed to click here to discuss your legal rights and to submit their information now.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL6J4ktk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","GRAL","LU2095319765.USD","IE00B64PRP62.GBP","BK4112","IE00BKPKM429.USD","BK4139","LU2210149790.SGD","NDAQ","SG9999014013.SGD","BK4585","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616666963","title":"Grail Grants 19,500 RSUs to 20 New Hires Under Nasdaq Inducement Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2616666963","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616666963?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:01","pubTimestamp":1772485273,"startTime":"0","endTime":"0","summary":"Grail Inc. granted restricted stock units covering a total of 19,500 shares to 20 recently hired non-executive employees under its Inducement Equity Incentive Plan. The awards vest over about four years, with 25% vesting on Feb. 28, 2027 and the remainder vesting on each subsequent one-year anniversary, subject to continued employment through each vesting date.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5v7nYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616236659","title":"Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616236659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616236659?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:01","pubTimestamp":1772485260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA9BZYXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616807455","title":"Levi & Korsinsky Probes Grail Inc. for Possible Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2616807455","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616807455?lang=en_us&edition=fundamental","pubTime":"2026-03-02 13:55","pubTimestamp":1772430943,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has opened an investigation into Grail Inc. over possible federal securities-law violations, focusing on prior statements about the company’s 2025 cash-burn guidance and projected cash runway into 2030 tied to planned clinical and regulatory milestones. The firm is seeking to hear from investors who incurred losses in Grail securities.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLc2tr7w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614074924","title":"Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074924","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074924?lang=en_us&edition=fundamental","pubTime":"2026-02-27 06:00","pubTimestamp":1772143200,"startTime":"0","endTime":"0","summary":"Grail's highflying stock got cut in half last Friday.The diagnostics company's stock climbed fivefold last year, in part on expectations for a U.K. national study of Grail's blood test that detects dozens of cancers before they are symptomatic. Annual screenings of 140,000 older Brits was hoped to reduce the number of late-stage cancers appearing in the group, after three years.It didn't, and that news last week took Grail shares down from $101 to $50, in a day.After five days of elevated turnover, by Thursday investors seem to have finished their rethinking on the stock. Trading volume returned to an average level and the shares ended the day almost 12% higher, at $58.10.Grail and its fans had hoped the study by Britain's National Health Service would show that detecting cancers early, when they s treatable, would leave fewer late-stage cancers  in a population -- saving jobs, lives and medical expenses. Grail thinks there were fewer Stage IV cancers, but the Stage III cases didn't dr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","LU2211815571.USD","IE00BJT1NW94.SGD","BK4535","LU2468319806.SGD","BK4581","IE00B2B36J28.USD","GRAL","LU0882574055.USD","LU0266013472.USD","LU1691799644.USD","BK4592","LU2237957902.USD","IE0002141913.USD","LU2324357040.USD","ISBC","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1914381329.SGD","BK4588","BK4568","LU1023059063.AUD","LABU","LU0122379950.USD","LU0058720904.USD","LU2133065610.SGD","SG9999004303.SGD","BK4082","LU0868494617.USD","LU1061106388.HKD","BK4551","BK4139","LU2237957811.SGD","SG9999002224.SGD","IE0009355771.USD","GH","LU1721429741.USD","LU1989763690.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1989763427.SGD","BK4585","LU1721429402.USD","BK4566","BK4504","LU0170899867.USD","SG9999002232.USD","ABT","SGXZ41872573.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614548740","title":"GRAIL to Present at TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614548740","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614548740?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:02","pubTimestamp":1771966976,"startTime":"0","endTime":"0","summary":"GRAIL to Present at TD Cowen 46th Annual Health Care Conference               Grail Inc. said its management will present at the TD Cowen 46th Annual Health Care Conference in Boston on March 3 at 10:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL1mpTwt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614742399","title":"Levi & Korsinsky probes Grail Inc. for possible securities fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2614742399","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614742399?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:25","pubTimestamp":1771961120,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has opened an investigation into Grail Inc. over potential violations of federal securities laws. The probe focuses on statements about 2025 cash-burn guidance and the company’s projected cash runway into 2030, including funding expectations tied to planned clinical and regulatory milestones. Investors who suffered losses in Grail securities are being invited to contact the firm about a potential recovery.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLc0mGfP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":141,"code":"91000000","status":"200"}]}}